Evidence map›Paper›PMID 27224979›Full record

ArticleAIDS and behavior2017

Vaginal Prostate Specific Antigen (PSA) Is a Useful Biomarker of Semen Exposure Among HIV-Infected Ugandan Women.

Sarah E Woolf-King, Winnie Muyindike, Marcia M Hobbs, Adrine Kusasira, Robin Fatch, Nneka Emenyonu, Mallory O Johnson, Judith A Hahn

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in AIDS and behavior, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. PrEP Use Among Female Sex Workers: No Evidence for Risk Compensation.Journal of acquired immune deficiency syndromes (1999) · 2019
    Observational
  3. Article
  4. Observational
  5. Article
  6. Citizen Science for Mining the Biomedical Literature.Citizen science : theory and practice · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Sarah E Woolf-KingDepartment of Medicine, University of California, San Francisco (UCSF), San Francisco, CA, USA. sarah.woolf-king@ucsf.edu.
Winnie MuyindikeMbarara University of Science and Technology (MUST), Mbarara, Uganda.
Marcia M HobbsSchool of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Adrine KusasiraMbarara University of Science and Technology (MUST), Mbarara, Uganda.
Robin FatchDepartment of Medicine, University of California, San Francisco (UCSF), San Francisco, CA, USA.
Nneka EmenyonuDepartment of Medicine, University of California, San Francisco (UCSF), San Francisco, CA, USA.
Mallory O JohnsonDepartment of Medicine, University of California, San Francisco (UCSF), San Francisco, CA, USA.
Judith A HahnDepartment of Medicine, University of California, San Francisco (UCSF), San Francisco, CA, USA.
University of California, San Francisco · USMbarara University of Science and Technology · UGUniversity of North Carolina at Chapel Hill · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Ujima Mentoring ProgramP30MH062246 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Sheri Ann Lippman · 2001 to 2026
$57.4M
Trichomonas Typing SystemU19AI031496 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HOBBS, MARCIA METZGAR · 1995 to 2014
$24.9M
URBAN ARCH (3/5) Uganda Cohort TB preventive therapy for HIV-infected alcohol users in Uganda: an evaluation of safety tolerability and adherenceU01AA020776 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAHN, JUDITH ALISSA · 2011 to 2021
$4.7M
Changes in Alcohol Consumption in HIV Positives in UgandaR01AA018631 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAHN, JUDITH ALISSA · 2010 to 2013
$2.0M
Training in Research Program on Alcohol Use by Persons with our at Risk for HIVK24AA022586 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAHN, JUDITH ALISSA · 2013 to 2023
$1.8M
Mentoring and Empowerment in the Context of HIV Care for At-Risk PopulationsK24DA037034 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSON, MALLORY O · 2014 to 2018
$918k
Alcohol Use and High Risk Behavior Among HIV-Positive MenK01AA021671 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WOOLF-KING, SARAH E · 2013 to 2017
$865k
NIAAA NIH HHS K01 AA021671NIAAA NIH HHS K24 AA022586NIAAA NIH HHS R01 AA018631NIAAA NIH HHS U01 AA020776NIAID NIH HHS P30 AI027763NIAID NIH HHS P30 AI050410NIAID NIH HHS U19 AI031496NIDA NIH HHS K24 DA037034NIMH NIH HHS P30 MH062246
6 · The paper itself

Abstract

The practical feasibility of using prostate specific antigen (PSA) as a biomarker of semen exposure was examined among HIV-infected Ugandan women. Vaginal fluids were obtained with self-collected swabs and a qualitative rapid test (ABAcard

Indexed as

HIV InfectionsSelf ReportUnsafe SexAdultBiomarkersFemaleHumansProstate-Specific AntigenSemenUgandaVaginaYoung AdultBiomarkersProstate-Specific AntigenBiomarkerCondom useHIVProstate specific antigenSelf-report

Identifiers

PMID27224979
PMCPMC5123961
OpenAlexW2402254067

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.